Join us in celebrating the launch of Project 1st STOP (Safe Treatment and Overdose Prevention)—JSAS HealthCare’s new Mobile Medication Unit
Neptune, NJ — August 2025 — JSAS HealthCare, Inc. (JSASHC) is proud to announce it has been awarded funding through
When it comes to the opioid crisis, collaboration makes all the difference. Join us at the Mobile Health Leadership Summit
In September 2024, JSAS HealthCare was awarded funding through a competitive Request for Proposal process by the New Jersey Department
Maiysha Ware, NJATOD President, accepted the notable Nyswander/Dole “Marie” Award which is the highest accolade AATOD can bestow on someone
Explore NJATOD’s latest advocacy efforts detailed in a comprehensive letter addressing the 42 CFR Part 8 Final Rule. This crucial
New Jersey is making significant strides in expanding access and eliminating transportation barriers to medication-assisted treatment for opioid use disorders.
The New Jersey Association for the Treatment of Opioid Dependence (NJATOD) expresses strong concerns over the Modernizing Opioid Treatment Access
